Sign up Australia
Proactive Investors - Run By Investors For Investors

WeedMD steps up adult-use plans as it inks sales deal with Lisa Campbell's Lifford Cannabis Solutions

Lifford helps licensed cannabis companies to get their products successfully through control boards to retail
WeedMD steps up adult-use plans as it inks sales deal with Lisa Campbell's Lifford Cannabis Solutions
Lifford helps licensed cannabis companies to get their products successfully through to retail stage

Cannabis group WeedMD Inc (CVE:WMD; OTCQX:WDDMF) says it's delighted to have struck a multi-year retail sales distribution agreement with Lifford Cannabis Solutions, which is led by media personality and long-time advocate of pot Lisa Campbell.

Lifford helps licensed cannabis companies to get their products successfully through control boards to retail.

In this case, it will represent WeedMD’s premium cannabis brands and products for the adult-use retail market in British Columbia and Alberta.

“Lifford Cannabis Solutions is delighted to be working with WeedMD, a licensed producer widely recognized as a groundbreaking cultivator in Canada," said Lisa Campbell.

"With some of the most unique genetics on the market, we are excited to elevate WeedMD through our four-pillared approach which combines distribution, education, innovation and relationships,”

She added: "We are confident that WeedMD’s top-shelf cannabis - which is sustainably grown by a team that is deeply rooted in the cannabis community - will be well-suited to consumers in the west. It is an honour to collaborate with the WeedMD team as they continue to grow across Canada."

Brett Moon of WeedMD added: "With the onset of legalization, WeedMD’s products are garnering the attention of a discerning and knowledgeable cannabis audience.

"Lifford has a history of delivering great results in the alcohol beverage category and has developed strong relationships with the provincial distributors as well as key customers."

Last week, WeedMD and Blockstrain Technology Corp (TSXV:DNAX, OTC:BKKSF) kicked off the launch of Blockstrain’s proprietary genome tracking software after registering WeedMD’s cannabis plant DNA.

Blockstrain has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

Related Articles

Laboratory testing
October 10 2018
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
medical cannabis
October 01 2018
The companies will collaborate on activities to develop cannabinoid medicines as a medical option in Chile.
cannabis leaf and green tablets
October 30 2018
The company will now proceed with stage II of the human clinical trial.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use